# Selective Retina Therapy With Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients

> **NCT03339856** · NA · COMPLETED · sponsor: **Kim's Eye Hospital** · enrollment: 16 (actual)

## Conditions studied

- Central Serous Chorioretinopathy

## Interventions

- **DEVICE:** Selective retina therapy

## Key facts

- **NCT ID:** NCT03339856
- **Lead sponsor:** Kim's Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2017-09-01
- **Final completion:** 2017-10-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03339856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03339856, "Selective Retina Therapy With Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03339856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*